Clinicians aim for the lowest dose that still helps regulate appetite and stabilize weight
Moreover, SCFAs, dose-dependently, which effects dependent on the specific SCFA, segment of the colon animal species and experimental models, may impact IBS-D with increased transit rate
This gradual increase helps your body adjust to the medication while minimizing potential side effects
Some GLP-1 agonists also target an additional set of receptors called glucose-dependent insulinotropic polypeptide (GIP) receptors
It starts a lot of times with deciding you really cant live that way anymore, Hall said
Tuteja, R.) 141171 (Academic Press, 2019)